Processa Pharmaceuticals, Inc. (PCSA)
NASDAQ: PCSA · Real-Time Price · USD
2.660
-0.020 (-0.75%)
May 5, 2026, 4:00 PM EDT - Market closed
Processa Pharmaceuticals Market Cap
Processa Pharmaceuticals has a market cap or net worth of $7.08 million as of May 5, 2026. Its market cap has increased by 489.64% in one year.
Market Cap
7.08M
Enterprise Value
1.54M
1-Year Change
489.64%
Ranking
Category
Stock Price
$2.66
Market Cap Chart
Since October 2, 2020, Processa Pharmaceuticals's market cap has decreased from $34.40M to $7.08M, a decrease of -79.43%. That is a compound annual growth rate of -24.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 4, 2026 | 7.10M | 9.23% |
| Dec 31, 2025 | 6.50M | 124.14% |
| Dec 31, 2024 | 2.90M | -64.63% |
| Dec 29, 2023 | 8.20M | -53.41% |
| Dec 30, 2022 | 17.60M | -77.14% |
| Dec 31, 2021 | 77.00M | 10.47% |
| Dec 31, 2020 | 69.70M | 102.62% |
| Oct 2, 2020 | 34.40M | - |
View and export this data all the way back to 2020. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Silo Pharma | 7.40M |
| Addex Therapeutics | 7.39M |
| TransCode Therapeutics | 7.18M |
| Aptorum Group | 7.17M |
| BioAtla | 7.08M |
| Immuron | 7.04M |
| Xenetic Biosciences | 6.80M |
| Can-Fite BioPharma | 6.69M |